Research

A new biotech startup in Dallas aims to speed the development of treatments for rare neurological diseases that disproportionately affect children. Taysha Gene Therapies, launched Tuesday with $30 million in seed financing, has partnered with UT Southwestern researchers whose mission is to eradicate genetic diseases that can deprive children of the ability to walk, talk,…

The National Institutes of Health has once again renewed a five-year contract with the University of Pennsylvania’s gene therapy program, which will receive $13 million to support the advancement of gene-therapy research to the clinic. The contract was awarded by National Heart, Lung and Blood Institute to what operates as the Gene Therapy Program Preclinical…